S J M Jones
Overview
Explore the profile of S J M Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Titmuss E, Milne K, Jones M, Ng T, Topham J, Brown S, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596550
The journal's Editorial Office and Editorial Board are jointly issuing a resolution and removal of the linked to this article [...].
2.
Titmuss E, Milne K, Jones M, Ng T, Topham J, Brown S, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982943
Colorectal cancers are one of the most prevalent tumour types worldwide and, despite the emergence of targeted and biologic therapies, have among the highest mortality rates. The Personalized OncoGenomics (POG)...
3.
Pleasance E, Bohm A, Williamson L, Nelson J, Shen Y, Bonakdar M, et al.
Ann Oncol
. 2022 Jun;
33(9):939-949.
PMID: 35691590
Background: Recent advances are enabling delivery of precision genomic medicine to cancer clinics. While the majority of approaches profile panels of selected genes or hotspot regions, comprehensive data provided by...
4.
Jones M, Lim H, Shen Y, Pleasance E, Chng C, Reisle C, et al.
Ann Oncol
. 2017 Sep;
28(12):3092-3097.
PMID: 28950338
Background: NRG1 fusion-positive lung cancers have emerged as potentially actionable events in lung cancer, but clinical support is currently limited and no evidence of efficacy of this approach in cancers...
5.
Sheffield B, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, et al.
Curr Oncol
. 2017 Jan;
23(6):e571-e575.
PMID: 28050146
Background: Gastrointestinal carcinomas are genomically complex cancers that are lethal in the metastatic setting. Whole-genome and transcriptome sequencing allow for the simultaneous characterization of multiple oncogenic pathways. Methods: We report...
6.
Jones M, Schrader K, Shen Y, Pleasance E, Chng C, Dar N, et al.
Ann Oncol
. 2016 Mar;
27(5):801-6.
PMID: 27022066
Background: A patient suffering from metastatic colorectal cancer, treatment-related toxicity and resistance to standard chemotherapy and radiation was assessed as part of a personalized oncogenomics initiative to derive potential alternative...
7.
Tennant B, Robertson A, Kramer M, Li L, Zhang X, Beach M, et al.
Diabetologia
. 2012 Dec;
56(3):542-52.
PMID: 23238790
Aims/hypothesis: The paucity of information on the epigenetic barriers that are blocking reprogramming protocols, and on what makes a beta cell unique, has hampered efforts to develop novel beta cell...
8.
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
Wang G, Jones S, Marra M, Sadar M
Oncogene
. 2006 Jun;
25(55):7311-23.
PMID: 16751804
Progression of prostate cancer to androgen independence is suspected to involve the androgen and protein kinase A (PKA) signaling pathways. Here for the first time, the transcriptomes associated with each...
9.
Montgomery S, Griffith O, Sleumer M, Bergman C, Bilenky M, Pleasance E, et al.
Bioinformatics
. 2006 Jan;
22(5):637-40.
PMID: 16397004
Motivation: Our understanding of gene regulation is currently limited by our ability to collectively synthesize and catalogue transcriptional regulatory elements stored in scientific literature. Over the past decade, this task...
10.
Robertson G, Bilenky M, Lin K, He A, Yuen W, Dagpinar M, et al.
Nucleic Acids Res
. 2005 Dec;
34(Database issue):D68-73.
PMID: 16381958
We describe cisRED, a database for conserved regulatory elements that are identified and ranked by a genome-scale computational system (www.cisred.org). The database and high-throughput predictive pipeline are designed to address...